Tutorials
Immunogen Inc logo

Immunogen Inc

$ 5.45 +0.01 (+0.18%) 10:08 PM EST
P/E:
At Loss
P/B:
4.81
Market Cap:
$ 1.20B
Enterprise V:
$ 846.14M
Volume:
3.63M
Avg Vol (2M):
3.28M
Also Trade In:
Volume:
3.63M
Market Cap $:
1.20B
PE Ratio:
At Loss
Avg Vol (2-Month):
3.28M
Enterprise Value $:
846.14M
PB Ratio:
4.81
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Immunogen Inc
NAICS : 325412 SIC : 2834
830 Winter Street, Waltham, MA, USA, 02451
Description
Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent. The technology is used in Kadcyla (ado-trastuzumab emtansine)--a registered trademark of Genentech, a member of the Roche Group--to kill solid tumors. Companies such as Amgen, Genentech/Roche, Lilly, Novartis, Sanofi, and Takeda have licensed limited rights to use the ADC technology in their therapies.
Name Current Vs Industry Vs History
Cash-To-Debt 21.83
Equity-to-Asset 0.59
Debt-to-Equity 0.07
Debt-to-EBITDA -0.11
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.09
Distress
Grey
Safe
Beneish M-Score -3.09
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 69.89
9-Day RSI 62.73
14-Day RSI 60.59
6-1 Month Momentum % -7.89
12-1 Month Momentum % -13.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.52
Quick Ratio 4.52
Cash Ratio 4.29
Days Sales Outstanding 5.55

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.8

Financials (Next Earnings Date:2022-10-28 Est.)

IMGN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:IMGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 89.442
EPS (TTM) ($) -0.69
Beta 0.55
Volatility % 52.36
14-Day RSI 60.59
14-Day ATR ($) 0.353346
20-Day SMA ($) 5.109
12-1 Month Momentum % -13.88
52-Week Range ($) 3.095 - 7.77
Shares Outstanding (Mil) 220.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Immunogen Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More